Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL3989960

SELADELPAR LYSINE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CCO[C@H](COc1ccc(C(F)(F)F)cc1)CSc1ccc(OCC(=O)O)c(C)c1.NCCCC[C@H](N)C(=O)O.O.O
ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID CHEMBL3989960
Name SELADELPAR LYSINE
Phase Approved
Structure Type MOL
InChI Key WTKSWPYGZDCUNQ-JZXFCXSPSA-N
Therapeutic ✓ Yes
Parent Compound CHEMBL230158
Active Moiety CHEMBL230158

Known Names

Livdelzi MBX-8025 lysine Mbx-8025 lysine dihydrate Mbx-8025 lysine salt, dihydrate Seladelpar lysine Seladelpar lysine dihydrate
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
6
Known Names
1
Indications
1
Mechanisms

Molecular Properties

444.5
MW (Da)
5.05
ALogP
5
HBA
1
HBD
65.0
PSA (Ų)
0.49
QED
1
Ro5 Violations
11
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2024
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Oral
USAN Stem -delpar
USAN Year 2017

Extended Properties

Molecular Formula C27H41F3N2O9S
MW 626.69
Aromatic Rings 2
Heavy Atoms 30
NP-Likeness -0.87

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Peroxisome proliferator-activated receptor delta agonist AGONIST Peroxisome proliferator-activated receptor delta ✓ ✓

Indications

Liver Cirrhosis, Biliary

Data from ChEMBL 36 via Core Engine